Non-Enzymatic Glycosylation Reduces Antithrombin III Activity

• References

• 1 Banerjee RN, Sahni AL, Kumar V, Arya M. Antithrombin III deficiency in maturity onset diabetes mellitus and atherosclerosis. Thrombos Diathes Haemorrh 1974; 31: 339-345
• 2 Ceriello A, Dello Russo P, Zuccotti C, Florio A, Nazzaro S, Pietran-tuono C, Rosato GB. Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation. A preliminary report Thromb Haemostas 1983; 50: 633-634
• 3 Mallia AK, Hermanson GT, Krojn RF, Fujimoto EK, Smith PK. Preparation and use of a boronic acid affinity support for separation and quantitation of glycosylated hemoglobins. Anal Lett 1981; 14: 133-137
• 4 Abildgaard U, Lie M, Odegard OR. Antithrombin (heparin co-factor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH). Thromb Res 1977; 11: 549-554
• 5 Calles-Escandon J, Ruiz-Arguellas GS, Pedros-Semorile MG, Lan-zetti-de-Peschard C, Cordova MS, Lozano O. Fibrinogen glucosylation in human diabetes mellitus. Blood 1981; 58: 213 A
• 6 Browlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin. Diabetes 1983; 32: 680-684